Company Location | New York |

For RNAi mechanistic research and RNAi application in viral illnesses, examining the host-virus interaction is essential. Since RNA interference (RNAi) is a therapeutic approach that targets several stages of the infectious viral lifecycle, including as replication, transcription, assembly, and budding from target cells, it may be utilized to treat both RNA and DNA viruses. In order to support research from mechanism to clinical translational application, Creative Biolabs offers a comprehensive variety of RNAi anti-monkeypox drug development options.
Check more: RNA interference (RNAi)-based Anti-Monkeypox Drug Discovery Solutions at Creative Biolabs
Current job openings at Creative Biolabs
- Currently this employer doesn't have any openings.